+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acne Therapeutics Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129676
Global Acne Therapeutics Market Size, Share & Trends Analysis Report by Treatment (Medication and Other Treatment), By Route of Administration (Oral, Topical, and Parenteral), and Forecast, 2020-2026
The global acne therapeutics market is projected to grow significantly during the forecast period. The primary factors that drive the growth of the global acne therapeutics industry include changing lifestyles of peoples; increased consumption of junk food, sedentary lifestyles, and smoking, which results in acne breakout which, in turn, drives the market growth during the forecast period. Besides, rising disposable income and increased awareness amongst the peoples regarding acne treatment is expected to propel the market growth during the forecast period. The market also offers a lucrative opportunity for players in the dermatology care industry due to the rise in the adoption of acne cure products along with the enhancements in the economic standards of the population.

The global acne therapeutics market is segmented on the basis of treatment, and route of administration. Based on the treatment, the market is further segmented into medications that include and other treatment. The medication segment further includes retinoids, antibiotics, hormonal drugs, anti-inflammatory drugs, and others. Whereas the other treatment options include laser & photodynamic therapy, chemical peel, and extraction of whiteheads & blackheads. The medication segment is likely to hold the most significant share in the market. Based on the route of administration, the market is segmented into the oral, topical, and parenteral route of administration. The topical segment is projected to hold a significant market share during the forecast period.

Geographically, the study of the global acne therapeutics market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global acne therapeutics market during the forecast period. while North America is estimated to hold a prominent share in the market.

Moreover, the study of the global cluster headache market report covers the analysis of various players operating in the market. Some of the prominent players operating in the include Aclaris Therapeutics Inc., Allergan PlcEli Lilly and Co., F. Hoffmann-La Roche AG, LEO Pharma A/S, GlaxoSmithKline Plc, Mylan NV, Novartis AG, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Alma Lasers Ltd., Cynosure Inc., Suneva Medical Inc., and others. In January 2019, LEO Pharma and Bayer announced the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma.

Research Methodology

The market study of the global acne therapeutics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for acne therapeutics market players, drug manufacturing companies, investment companies, industry associations and experts, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Acne Therapeutics Market Research and Analysis by Treatment
2. Global Acne Therapeutics Market Research and Analysis by Route of Administration

The Report covers:
  • Comprehensive research methodology of the global acne therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global acne therapeutics market.
  • Insights about market determinants which are stimulating the global acne therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Acne Therapeutics Market by Treatment
5.1.1. Medication Retinoids Antibiotics Hormonal Drugs Anti-inflammatory Drugs Others
5.1.2. Other Treatment
5.2. Global Acne Therapeutics Market by Route of Administration
5.2.1. Oral
5.2.2. Topical
5.2.3. Parenteral
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Aclaris Therapeutics Inc.
7.2. Allergan Plc
7.3. Alma Lasers Ltd.
7.4. Amgen Inc.
7.5. Aurobindo Pharma Ltd.
7.6. Bausch Health Companies Inc.
7.7. Cipher Pharmaceuticals Inc.
7.8. Cutera Inc.
7.9. Cynosure, Inc.
7.10. Eli Lilly and Co.
7.11. F. Hoffmann-La Roche Ltd.
7.12. Galderma SA
7.13. GlaxoSmithKline Plc
7.14. Johnson & Johnson Services Inc.
7.15. LEO Pharma A/S
7.16. Lumenis Ltd.
7.17. Mylan NV
7.18. Novartis International AG
7.19. Pfizer Inc.
7.20. Sun Pharmaceutical Industries Ltd.
7.21. Suneva Medical, Inc.
7.22. Syneron Medical Ltd.
7.23. TevaPharmaceuticals Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aclaris Therapeutics Inc.
  • Allergan Plc
  • Alma Lasers Ltd.
  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Bausch Health Companies Inc.
  • Cipher Pharmaceuticals Inc.
  • Cutera Inc.
  • Cynosure, Inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Galderma SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • LEO Pharma A/S
  • Lumenis Ltd.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Suneva Medical, Inc.
  • Syneron Medical Ltd.
  • TevaPharmaceuticals Industries Ltd.